3,652
Views
12
CrossRef citations to date
0
Altmetric
Research Articles

Using Cost-Effectiveness Evidence to Inform Decisions as to which Health Services to Provide

Pages 32-38 | Received 21 Oct 2015, Accepted 20 Nov 2015, Published online: 21 Jan 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

André Soares Santos, Augusto Afonso Guerra-Junior, Brian Godman, Alec Morton & Cristina Mariano Ruas. (2018) Cost-effectiveness thresholds: methods for setting and examples from around the world. Expert Review of Pharmacoeconomics & Outcomes Research 18:3, pages 277-288.
Read now
Abdo S. Yazbeck. (2016) The Newest Three-Letter Fad in Health: Can HTA Escape the Fate of NHA, CEA, GBD?. Health Systems & Reform 2:2, pages 102-105.
Read now

Articles from other publishers (10)

Tara Coffin, Deborah Bowen, Elizabeth Swisher, Karen Lu, Nadine Rayes, Barbara Norquist, Stephanie Blank, Douglas Levine, Jamie Bakkum-Gamez, Gini Fleming, Olufunmilayo Olopade, Alan D’Andrea, Denise Nebgen, Christine Peterson, Mark Munsell, Kathleen Gavin, Rebecca Lechner, Jamie Crase, Deborah Polinsky & Iris Romero. (2022) An Accessible Communication System for Population-Based Genetic Testing: Development and Usability Study. JMIR Formative Research 6:10, pages e34055.
Crossref
Michael J. Tildesley, Anna Vassall, Steven Riley, Mark Jit, Frank Sandmann, Edward M. Hill, Robin N. Thompson, Benjamin D. Atkins, John Edmunds, Louise Dyson & Matt J. Keeling. (2022) Optimal health and economic impact of non-pharmaceutical intervention measures prior and post vaccination in England: a mathematical modelling study. Royal Society Open Science 9:8.
Crossref
Peter S Hendricks, Heith Copes, Neiloufar Family, Luke TJ Williams, David Luke & Shlomi Raz. (2022) Perceptions of safety, subjective effects, and beliefs about the clinical utility of lysergic acid diethylamide in healthy participants within a novel intervention paradigm: Qualitative results from a proof-of-concept study. Journal of Psychopharmacology 36:3, pages 337-347.
Crossref
Siti Norain Azahar, Saperi Sulong, Wan Asyraf Wan Zaidi, Norliza Muhammad, Yusof Kamisah & Norliana Masbah. (2022) Direct Medical Cost of Stroke and the Cost-Effectiveness of Direct Oral Anticoagulants in Atrial Fibrillation-Related Stroke: A Cross-Sectional Study. International Journal of Environmental Research and Public Health 19:3, pages 1078.
Crossref
Marc Kowalkowski, Tara Eaton, Andrew McWilliams, Hazel Tapp, Aleta Rios, Stephanie Murphy, Ryan Burns, Bella Gutnik, Katherine O’Hare, Lewis McCurdy, Michael Dulin, Christopher Blanchette, Shih-Hsiung Chou, Scott Halpern, Derek C. Angus & Stephanie P. Taylor. (2021) Protocol for a two-arm pragmatic stepped-wedge hybrid effectiveness-implementation trial evaluating Engagement and Collaborative Management to Proactively Advance Sepsis Survivorship (ENCOMPASS). BMC Health Services Research 21:1.
Crossref
Mac Ardy Junio Gloria, Montarat Thavorncharoensap, Usa Chaikledkaew, Sitaporn Youngkong, Ammarin Thakkinstian & Anthony J. Culyer. (2021) A Systematic Review of Demand-Side Methods of Estimating the Societal Monetary Value of Health Gain. Value in Health 24:10, pages 1423-1434.
Crossref
Jaak Ph. Janssens, Klaus Schuster & Andreas Voss. (2018) Preventive, predictive, and personalized medicine for effective and affordable cancer care. EPMA Journal 9:2, pages 113-123.
Crossref
David A. Watkins, Dean T. Jamison, Anne Mills, Rifat Atun, Kristen Danforth, Amanda Glassman, Susan Horton, Prabhat Jha, Margaret E. Kruk, Ole F. Norheim, Jinyuan Qi, Stéphane Verguet, David Wilson, Ala Alwan & Agnes Soucat. 2017. Disease Control Priorities, Third Edition (Volume 9): Improving Health and Reducing Poverty. Disease Control Priorities, Third Edition (Volume 9): Improving Health and Reducing Poverty 43 65 .
Martin Hensher, John Tisdell & Craig Zimitat. (2017) ?Too much medicine?: Insights and explanations from economic theory and research. Social Science & Medicine 176, pages 77-84.
Crossref
David A Watkins & Rachel A Nugent. (2017) Setting priorities to address cardiovascular diseases through universal health coverage in low- and middle-income countries. Heart Asia 9:1, pages 54-58.
Crossref